Healthcare FinTech Cylerity raises $4m to speed payments

October 29, 2025

Madison-based Cylerity, a healthcare FinTech company that uses AI to accelerate payments to providers, has raised $4m in an oversubscribed seed round and secured a debt facility worth up to $24m from First Business Bank.

The equity round was led by HealthX Ventures, with participation from C2 Ventures, Upstream Ventures, Wisconsin Investment Partners, and Tundra Angels. The capital injection highlights growing investor confidence in Cylerity’s mission to solve one of healthcare’s most persistent financial challenges—slow reimbursements from insurers.

Cylerity’s platform leverages AI-enabled anomaly detection and machine learning valuation models to predict when claims will be paid and their reimbursement value. This allows healthcare providers to access funds within 24 hours of submitting claims.

The newly raised capital will be used to expand Cylerity’s engineering and data science teams and strengthen its partnerships with healthcare and financial institutions nationwide.

Cylerity CEO Ryan Wheeler said, “Providers shouldn’t have to wait months to get paid for care they’ve already delivered. By valuing receivables in real time, we give practices the financial predictability they need to keep operations running smoothly and patients cared for without disruption.”

HealthX Ventures managing partner Mark Bakken said, “Cylerity is tackling one of healthcare’s biggest pain points—payment delays—by bridging the gap between care delivery and reimbursement. We’ve seen firsthand how their platform brings stability to providers and helps them stay focused on patients instead of paperwork by allowing them to get paid within a few days instead of potentially months.”

For early adopters such as Inspire Health Alliance, the platform’s impact has been immediate. Inspire Health Alliance founder and CEO Ricardo Salas said, “During the pandemic, we struggled to cover expanding payroll and keep up with diagnostic supply costs while serving clients and waiting on reimbursements. Cylerity changed that. They gave us access to affordable capital when we needed it most—and ultimately, we became investors ourselves because we believe in what they’re building.”